Investor FAQs

 

Myriad Genetics was founded in May 1991.

Our corporate headquarters and all our facilities are located at 320 Wakara Way, Salt Lake City, Utah

We completed our initial public offering in October 1995.

Our CUSIP number is 62855J104.

Our common stock is listed on the Nasdaq Global Select Market under the symbol "MYGN."

You may purchase our stock through a registered stock broker, bank or through a financial institution that provides brokerage services. Myriad Genetics does not offer a direct purchase plan for investors.

Our fiscal year ends on June 30.

First quarter – September 30 Second quarter – December 31 Third quarter – March 31 Fourth quarter – June 30

Our transfer agent is American Stock Transfer & Trust Company. They are responsible for maintaining all records of registered shareholders (including change of address and name), cancelling or issuing stock certificates and resolving problems related to lost, destroyed or stolen certificates. If your shares are held in Street name, you will have to contact your broker for these services. You may contact our transfer agent at:

American Stock Transfer & Trust Company 59 Maiden Lane New York, New York 10038 (800) 937-5449 (718) 921-8124 www.amstock.com

If you have questions about your shareholder account you should contact our transfer agent, American Stock Transfer & Trust Company at (800) 937-5499.

Please contact Scott Gleason, Investor Relations, at: 801-584-1143

sgleason@myriad.com

Please submit your question using the form below.

* Indicates required field